RA
GDRX icon

Rise Advisors’s GoodRx Holdings GDRX Stock Holding History

Rise Advisors’s Portfolio GDRX Stock Details GDRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-40
Closed -$278 – 1152
2024
Q3 		$278 Hold
40
– – ﹤0.01% 1208
2024
Q2 		$312 Hold
40
– – ﹤0.01% 1206
2024
Q1 		$284 Hold
40
– – ﹤0.01% 1233
2023
Q4 		$268 Hold
40
– – ﹤0.01% 589
2023
Q3 		$225 Hold
40
– – ﹤0.01% 612
2023
Q2 		$221 Hold
40
– – ﹤0.01% 651
2023
Q1 		$250 Hold
40
– – ﹤0.01% 775
2022
Q4 		$186 Hold
40
– – ﹤0.01% 742
2022
Q3 		$0 Hold
40
– – ﹤0.01% 720
2022
Q2 		$0 Hold
40
– – ﹤0.01% 716
2022
Q1 		$1K Hold
40
– – ﹤0.01% 603
2021
Q4 		$1.31K Buy
+40
New +$1.61K ﹤0.01% 580

Other funds holding GDRX

FPM
Francisco Partners Management San Francisco, California $292M AUM 34.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
LCM
Lakewood Capital Management New York $1.58B AUM 0.92% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
SLG
Silver Lake Group Menlo Park, California $3.68B AUM 7.22% 1-Year Est. Return
PTC
Petrus Trust Company Dallas, Texas $915M AUM 2.95% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
RRCP
Rip Road Capital Partners Boston, Massachusetts $62.5M AUM 1.22% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Rise Advisors's GDRX Position: Q4 2024 in Review

Rise Advisors sold out of GoodRx Holdings (GDRX) in Q4 2024, closing a stake of 40 shares — an estimated $278 sold.

Rise Advisors first reported a position in GDRX in Q4 2021 and held it in 12 quarters. The position peaked at $1.31K in Q4 2021. 170 funds tracked by Wall St. Rank hold GDRX as of Q4 2024.

  • Rise Advisors reported no remaining GoodRx Holdings position as of Q4 2024 after selling out during the quarter.
  • Rise Advisors sold 40 GoodRx Holdings shares in Q4 2024, an estimated $278.
  • Rise Advisors first reported a position in GoodRx Holdings in Q4 2021 and held it in 12 quarters.
  • Rise Advisors's GoodRx Holdings position peaked at $1.31K in Q4 2021.
  • 170 funds tracked by Wall St. Rank held GoodRx Holdings as of Q4 2024.

Based on Rise Advisors's 13F filing for Q4 2024, filed 7 Jan 2025.